trending Market Intelligence /marketintelligence/en/news-insights/trending/ef0ovhckxx423vup52aqgw2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Novelion Therapeutics names executive chair, interim CEO

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity


Novelion Therapeutics names executive chair, interim CEO

Canada's Novelion Therapeutics Inc. appointed Mark Corrigan to serve as executive chair of the board.

Further, COO Jeff Hackman was named interim CEO.

The company said in relation to Corrigan's appointment, the office of the CEO — comprising Corrigan, Hackman and former Chair Jason Aryeh — will be disbanded.

Novelion develops therapies for individuals with rare diseases.